In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 117 (1), 67-73
- https://doi.org/10.1007/bf02245100
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotilityDrug and Alcohol Dependence, 1993
- Characterization of Nicotinic Receptor‐Mediated [3H]Dopamine Release from Synaptosomes Prepared from Mouse StriatumJournal of Neurochemistry, 1992
- Nicotinic Modulation of [3H]Dopamine Release from Striatal Synaptosomes: Pharmacological CharacterisationJournal of Neurochemistry, 1990
- What is the nature of mecamylamine's antagonism of the central effects of nicotine?Biochemical Pharmacology, 1989
- Mecamylamine is a selective non-competitive antagonist of and aspartate-induced currents in horizontal cells dissociated from the catfish retinaNeuroscience Letters, 1988
- Characterization of N‐[3H]Methylcarbamylcholine Binding Sites and Effect of N‐Methylcarbamylcholine on Acetylcholine Release in Rat BrainJournal of Neurochemistry, 1988
- High affinity binding of [3H] (−)-nicotine to rat brain membranes and its inhibition by analogues of nicotineNeuropharmacology, 1988
- Intrathecal morphine in mice: A new techniqueEuropean Journal of Pharmacology, 1980
- Optically pure (+)-nicotine from (.+-.)-nicotine and biological comparisons with (-)-nicotineJournal of Medicinal Chemistry, 1979
- OBSERVATIONS ON THE PHARMACOLOGY OF CHOLINOCEPTIVE NEURONES IN THE RAT BRAIN STEMBritish Journal of Pharmacology, 1976